Recursion Pharmaceuticals(RXRX.US) Director Sells US$87,725.23 in Common Stock

$Recursion Pharmaceuticals(RXRX.US)$ Director Borgeson Blake sold 11,447 shares of common stock on Apr 16, 2024 at an average price of $7.6636 for a total value of $87,725.23.Source: Announcement What

moomoo NewsApr 18 17:56 ET

Recursion Pharmaceuticals(RXRX.US) Officer Sells US$367.01K in Common Stock

$Recursion Pharmaceuticals(RXRX.US)$ Officer Secora Michael sold 48,124 shares of common stock on Apr 16, 17, 2024 at an average price of $7.6263 for a total value of $367.01K.Source: Announcement Wha

moomoo NewsApr 18 17:56 ET

Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing

Michael Secora, Chief Financial Officer, on April 16, 2024, sold 48,124 shares in Recursion Pharmaceuticals (RXRX) for $367,007. Following the Form 4 filing with the SEC, Secora has control over a tot

MT NewswiresApr 18 17:15 ET

Recursion Pharmaceuticals (RXRX) Dips More Than Broader Market: What You Should Know

Yahoo FinanceApr 17 17:50 ET

Form 144 | Recursion Pharmaceuticals(RXRX.US) Officer Proposes to Sell 175.35K in Common Stocks

SEC FILLINGS DISCLOSED/ Apr 17, $Recursion Pharmaceuticals(RXRX.US)$ Officer Secora Michael intends to sell 23,124 shares of its common stock on Apr 17, with a total market value of approximately $175

moomoo NewsApr 17 16:21 ET

Where Will Recursion Pharmaceuticals Be in 5 Years?

The Motley FoolApr 17 07:00 ET